Clinical Trials Browser

INDUSTRY × Lymphoma × mocetinostat × Clear all

NCT00359086 2015-07-01

Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma

Phase 2 Completed

Lymphoma, Recurrence